BioSpace News Archive

Press Releases

Iovance Biotherapeutics Highlights Strong Fourth Quarter and Full Year 2025 Results, Business Achievements and Corporate Updates

February 24, 2026
·
13 min read
Press Releases

Axsome Therapeutics Initiates CLARITY Phase 3 Trial of Solriamfetol in Adults with Major Depressive Disorder with Excessive Daytime Sleepiness Symptoms

February 24, 2026
·
6 min read
Press Releases

AC Immune Initiates Phase 1 Clinical Trial of NLRP3 Inhibitor

February 24, 2026
·
6 min read
Press Releases

Indivior to Participate in Upcoming March 2026 Investor Conferences

February 24, 2026
·
1 min read
Press Releases

Monte Rosa Therapeutics Presents Updated Clinical Data from Phase 1/2 Study of MRT-2359 in Combination with Enzalutamide in Heavily Pretreated Metastatic Castration-Resistant Prostate Cancer Patients at ASCO Genitourinary Cancers Symposium (ASCO GU)

February 24, 2026
·
10 min read
Press Releases

Axogen, Inc. Reports Fourth Quarter and Full-Year 2025 Financial Results

February 24, 2026
·
16 min read
Press Releases

Larimar Therapeutics Announces FDA Breakthrough Therapy Designation for Nomlabofusp in FA and Reiterates Planned BLA Submission in June 2026

February 24, 2026
·
10 min read
Press Releases

Iovance Announces Positive Results from the First Clinical Trial for TIL Cell Therapy in Soft Tissue Sarcomas

February 24, 2026
·
9 min read
Press Releases

EyePoint Announces Participation at Upcoming March 2026 Investor Conferences

February 24, 2026
·
2 min read
Press Releases

Ocular Therapeutix™ to Participate in March 2026 Investor Conferences

February 24, 2026
·
2 min read